(Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | (Q2)Aug 31, 2022 | (Q1)May 31, 2022 | (FY)Feb 28, 2022 | (Q4)Feb 28, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 81.74%-88.33K | 95.07%-45.18K | 1.19%-802.02K | 14.13%-2.32M | 90.00%-113.41K | 55.84%-483.67K | -224.52%-916.17K | -314.11%-811.64K | -197.09%-2.71M | -20,017.97%-1.13M |
Net income from continuing operations | 84.81%-86.95K | 46.72%-429.96K | 69.02%-383.8K | 34.13%-4.12M | 62.03%-1.51M | 63.55%-572.4K | -117.62%-807.02K | -251.25%-1.24M | -232.79%-6.26M | -2,068.22%-3.97M |
Operating gains losses | -47.05%-121.04K | 537.61%58.76K | -3,634.15%-108.59K | -1,173.73%-148.5K | -409.00%-49.85K | -672.04%-82.31K | -184.48%-13.43K | 61.42%-2.91K | -41.16%13.83K | 118.10%16.13K |
Depreciation and amortization | -3.11%14.89K | -0.09%14.88K | -76.96%14.89K | -82.03%108.44K | -92.56%13.58K | -89.05%15.36K | -89.37%14.9K | -53.98%64.6K | 9.64%603.37K | 19.92%182.56K |
Asset impairment expenditure | --0 | --0 | --0 | -56.07%1.11M | -66.50%850K | --0 | --0 | --264.53K | --2.54M | --2.54M |
Remuneration paid in stock | 74.99%40.83K | 136.66%35K | -77.45%35K | -44.38%309.56K | -49.96%116.21K | -92.81%23.33K | --14.79K | --155.23K | --556.55K | --232.24K |
Other non cashItems | ---- | ---- | ---- | -82.39%20.74K | -81.61%9.36K | -80.89%2.94K | -80.56%7.83K | -94.58%605 | 9.45%117.73K | 876.80%50.89K |
Change In working capital | -50.74%63.94K | 307.23%276.13K | -553.96%-359.51K | 243.51%394.64K | 344.19%453.05K | 2,173.78%129.81K | -23.55%-133.25K | -533.97%-54.98K | -195.26%-275K | -253.60%-185.53K |
-Change in receivables | -891.51%-117K | 117.03%26.14K | -273.26%-73.84K | 139.89%117.54K | 138.41%240.26K | -125.54%-11.8K | 48.56%-153.53K | 129.77%42.62K | -395.33%-294.66K | 2,378.39%100.77K |
-Change in inventory | --22.93K | --10.66K | --13.53K | ---154.6K | ---154.6K | --0 | --0 | --0 | --0 | ---- |
-Change in payables and accrued expense | 11.58%158.01K | 1,079.69%239.32K | -206.57%-299.2K | 2,096.37%431.7K | 228.32%367.4K | 449.65%141.61K | -89.36%20.29K | -162.62%-97.6K | -89.60%19.66K | -328.66%-286.31K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 81.72%-88.33K | 95.07%-45.18K | 1.19%-802.02K | 14.13%-2.32M | 89.96%-113.82K | 55.88%-483.26K | -224.52%-916.17K | -314.11%-811.64K | -197.09%-2.71M | -20,017.97%-1.13M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 0 | 91.74%-63.63K | 136.45%29.91K | 94.80%-14.24K | 94.05%-21.32K | -3.73%-57.98K | -430.10%-770.13K | -1,422.09%-82.07K |
Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -724.78%-686.85K | -160.18%-14.03K |
Net intangibles purchas and sale | --0 | --0 | --0 | 23.60%-63.63K | 143.96%29.91K | -78.16%-14.24K | -253.11%-21.32K | -4,691.98%-57.98K | -34.32%-83.28K | ---68.04K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | --0 | 91.74%-63.63K | 136.45%29.91K | 94.80%-14.24K | 94.05%-21.32K | -3.73%-57.98K | -430.10%-770.13K | -1,422.09%-82.07K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 135.05K | 100.35%10 | -60.12%687.67K | -52.01%1.94M | 625.39%214.43K | 0 | -100.55%-2.82K | 380.16%1.72M | 1,900.80%4.03M | -168.01%-40.81K |
Net issuance payments of debt | --0 | --0 | --0 | --0 | 202.27%12.89K | --0 | -104.30%-2.82K | 93.89%-10.07K | -539.76%-195.93K | -1,525.68%-12.6K |
Net common stock issuance | ---- | ---- | -60.35%687.67K | ---- | ---- | ---- | ---- | -18.19%1.73M | ---- | ---- |
Cash dividends paid | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | --0 |
Interest paid (cash flow from financing activities) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---7K | --0 |
Net other financing activities | --135.05K | --10 | ---- | -54.31%1.94M | -84.69%201.54K | ---- | ---- | ---- | 2,371.88%4.24M | 2,365.29%1.32M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --135.05K | 100.35%10 | -60.12%687.67K | -52.01%1.94M | 625.39%214.43K | --0 | -100.55%-2.82K | 380.16%1.72M | 1,900.80%4.03M | -168.01%-40.81K |
Net cash flow | ||||||||||
Beginning cash position | -92.18%43.75K | -94.10%88.82K | -68.75%202.29K | 593.47%647.24K | -96.64%63.85K | 716.54%559.8K | 660.69%1.51M | 593.47%647.24K | -90.23%93.33K | 3,332.89%1.9M |
Current changes in cash | 109.39%46.72K | 95.20%-45.17K | -113.38%-114.35K | -181.43%-452.77K | 110.39%130.53K | -127.08%-497.5K | -613.12%-940.32K | 697.22%854.53K | 165.03%556.03K | -2,665.70%-1.26M |
Effect of exchange rate changes | -19.70%1.25K | 101.84%103 | -77.46%889 | 468.44%7.81K | 831.57%7.91K | 154.42%1.56K | -326.26%-5.6K | 252.81%3.94K | 70.03%-2.12K | 107.66%849 |
End cash Position | 43.66%91.73K | -92.18%43.75K | -94.10%88.82K | -68.75%202.29K | -68.75%202.29K | -96.64%63.85K | 716.54%559.8K | 660.69%1.51M | 593.47%647.24K | 593.47%647.24K |
Free cash from | 82.25%-88.33K | 95.18%-45.18K | 7.77%-802.02K | 31.32%-2.39M | 93.10%-83.9K | 63.66%-497.5K | -46.29%-937.5K | -245.23%-869.62K | -229.13%-3.48M | -10,925.75%-1.22M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.